CLINICAL AND HUMAN TESTING
|
|
- Sydney Greene
- 5 years ago
- Views:
Transcription
1 CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with a genetic disorder.
2 HerediT CF Highly accurate carrier screen for clinically relevant cystic fibrosis mutations. A direct answer about a common genetic disorder. For couples considering having a child or those with a family history of cystic fibrosis, male infertility or for whom an ultrasound has indicated an increased risk for cystic fibrosis, the HerediT Cystic Fibrosis Carrier Screening laboratory-developed test provides highly accurate results on clinically relevant mutations. TEST PERFORMANCE DATA The HerediT Cystic Fibrosis carrier screening test includes the most comprehensive number of disease-causing mutations available (136 mutations). The performance characteristics of the HerediT CF test have been analytically validated using CFTR gene mutations shown to be phenotypically relevant.1,2,3. ETHNICITY DETECTION RATE POPULATION RISK RESIDUAL RISK AFTER A NEGATIVE SCREEN Caucaisan Ashkenazi 93% 1/25 1/344 Jewish 95% 1/24 1/461 Hispanic 82% 1/58 1/318 African American 76% 1/61 1/251 Asian 76% 1/25 1/208 1: Clinical and functional translation of CFTR. US CF Foundation, Johns Hopkins University, The Hospital for Sick Children Web site. Accessed Oct 4, : Update on Carrier Screening for Cystic Fibrosis, ACOG Committee Opinion No Obstet Gynecol. 2011;117(4): : Paladino T, et al. Comprehensive Cystic Fibrosis Screening Panel for the Detection of Clinically Relevant Mutations. Poster session presented at: American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting; 2013 June 20-23; Phoenix, AZ. Should you test your patients? More than 10 million Americans are carriers of the CF genetic mutation from across all racial and ethnic groups. The American Congress of Obstetricians and Gynecologists (ACOG) Committee on Genetics recommends cystic fibrosis carrier screening for all patients who are planning a pregnancy or seeking prenatal care. How is the test performed? The HerediT Cystic Fibrosis Carrier Screen test is performed on a simple blood or buccal (cheek) swab sample and results are typically reported within 20 working days.
3 HerediT UNIVERSAL Customizable, comprehensive carrier screening for 250+ genetic disorders. Clearly defined results. Clearly defined risks. The HerediT UNIVERSAL laboratory-developed test screens for mutations associated with more than 250 clinically relevant and impactful genetic conditions and presents categorized results to help with both interpretation and counseling. CUSTOMIZABLE TO MEET YOUR PARENT S NEEDS We offer three options for your convenience: COMPLETE PANEL The comprehensive option designed to test for mutations in over 250 genetic disorders. STANDARD PANEL Test for disorders guided by ACOG and ACMG recommendatioons. JEWISH ANCESTRY PANEL Test for over 65 conditions common in the Ashkenazi and Sephardic populations How is the test performed? The HerediT UNIVERSAL test is performed on a simple blood or buccal (cheek) swab sample and results are typically reported within 20 working days. How is the test performed? The HerediT Cystic Fibrosis Carrier Screen test is performed on a simple blood or buccal (cheek) swab sample and results are typically reported within 20 working days.
4 DISEASE LIST The following diseases are included in the HerediT UNIVERSAL test. *Standard panel Jewish Ancestry Panel [ACOG] = Recommended by ACOG [ACMG] = Recommended by ACMG Gene specific sequencing is available for most disorders. 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha Hydroxylase 17-Beta Hydroxysteroid Dehydrogenase 3 21-Hydroxylase-Deficient Classical Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Nonclassical Congenital Adrenal Hyperplasia 3-Beta-Hydroxysteroid Dehydrogenase 3-Methylcrotonyl-CoA Carboxylase : MCCA Related 3-Methylcrotonyl-CoA Carboxylase : MCCB Related 3-Methylglutaconic Aciduria: Type 3 3-Phosphoglycerate Dehydrogenase 5-Alpha Reductase 6-Pyruvoyl-Tetrahydropterin Synthase Abetalipoproteinemia Achromatopsia: CNGB3 Related Acrodermatitis Enteropathica Acyl-CoA Oxidase I Adenosine Deaminase Adrenoleukodystrophy: X-Linked Alkaptonuria Alpha Thalassemia [ACOG]* Alpha-1-Antitrypsin Alpha-Mannosidosis Alport Syndrome: COL4A3 Related Alport Syndrome: COL4A4 Related Alport Syndrome: X-linked Amegakaryocytic Thrombocytopenia Andermann Syndrome Androgen Insensitivity Syndrome: Complete Antley-Bixler Syndrome Argininosuccinate Lyase Aromatase ARSACS Arts Syndrome Aspartylglycosaminuria Ataxia with Vitamin E Ataxia-Telangiectasia Autosomal Recessive Polycystic Kidney Disease BBS1 Related BBS2 Related BBS10 Related BBS11 Related BBS12 Related Bare Lymphocyte Syndrome: Type II Bartter Syndrome: Type 4A Beta Thalassemia [ACOG]* Beta-Hexosaminidase Pseudodeficiency Beta-Ketothiolase Biotinidase Bloom Syndrome [ACMG]* Canavan Disease [ACOG/ACMG]* Carnitine Palmitoyltransferase IA Carnitine Palmitoyltransferase II Carpenter Syndrome Cartilage-Hair Hypoplasia Cerebrotendinous Xanthomatosis Charcot-Marie-Tooth Disease with Deafness: X-Linked: GJB1 Related Charcot-Marie-Tooth Disease with Deafness: X-Linked: PRPS1 Related Cholesteryl Ester Storage Disease Choreoacanthocytosis Choroideremia Chronic Granulomatous Disease: X-Linked Citrullinemia: Type I Classical Galactosemia Cohen Syndrome Combined Pituitary Hormone : PROP1 Related Congenital Disorder of Glycosylation: Type 1A: PMM2 Related Congenital Disorder of Glycosylation: Type 1B: MPI Related Congenital Disorder of Glycosylation: Type 1C: ALG6 Related Congenital Lipoid Adrenal Hyperplasia Congenital Neutropenia: Recessive Copper Transport Disorders Corneal Dystrophy and Perceptive Deafness Corticosterone Methyloxidase Creatine Transporter Defect Crigler-Najjar Syndrome Cystic Fibrosis [ACOG/ACMG]* Cystinosis D-Bifunctional Protein Diabetes: Recessive Permanent Neonatal Dihydropyrimidine Dehydrogenase Du Pan Syndrome Dystrophic Epidermolysis Bullosa: Recessive Ehlers-Danlos Syndrome: Type VIIC Ellis-van Creveld Syndrome: EVC Related Ellis-van Creveld Syndrome: EVC2 Related Emery-Dreifuss Myopathy: X-Linked Enhanced S-Cone Ethylmalonic Aciduria Fabry s Disease Factor IX Factor VIII Familial Chloride Diarrhea Familial Dysautonomia [ACOG/ ACMG]* Familial Hyperinsulinism: Type 1: ABCC8 Related Familial Hyperinsulinism: Type 2: KCNJ11 Related Familial Mediterranean Fever Familial Mediterranean Fever: Mild Form Fanconi Anemia: Type A Fanconi Anemia: Type C [ACMG]* Fanconi Anemia: Type G Fanconi Anemia: Type J Fragile X Syndrome* Fumarase Galactokinase Gaucher Disease [ACMG]* Gitelman Syndrome Globoid Cell Leukodystrophy Glucose-6-Phosphate Dehydrogenase Glutaric Acidemia: Type I Glycine Encephalopathy: AMT Related Glycine Encephalopathy: GLDC Related Type IA Type IB Type II Type III Type IV Type V Type VII GM1-Gangliosidoses GRACILE Syndrome Guanidinoacetate Methyltransferase Hemochromatosis: Type 2A: HFE2 Related Hemochromatosis: Type 3: TFR2 Related Hemoglobinopathy: Hb C [ACOG]* Hemoglobinopathy: Hb D [ACOG]* Hemoglobinopathy: Hb E [ACOG]* Hemoglobinopathy: Hb O [ACOG]* Hereditary Fructose Intolerance Herlitz Junctional Epidermolysis Bullosa: LAMB3 Related
5 Hermansky-Pudlak Syndrome: Type 1 Hermansky-Pudlak Syndrome: Type 3 HMG-CoA Lyase Holocarboxylase Synthetase Homocystinuria Caused by CBS Hunter Syndrome Hurler Syndrome Hypohidrotic Ectodermal Dysplasia: X-Linked Hypophosphatasia Inclusion Body Myopathy: Type 2 Isovaleric Acidemia Joubert Syndrome Juvenile Retinoschisis: X-Linked Lamellar Ichthyosis: Type 1 Laryngoonychocutaneous Syndrome CEP290 Related GUCY2D Related LCA5 Related RDH12 Related Leigh Syndrome: French- Canadian Leydig Cell Hypoplasia Type 2A Type 2B Type 2C Type 2D Type 2E Type 2F Type 2I Lipoprotein Lipase Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Lysinuric Protein Intolerance Maple Syrup Urine Disease: Type 1A Maple Syrup Urine Disease: Type 1B Maple Syrup Urine Disease: Type 3 Meckel Syndrome: Type 1 Medium-Chain Acyl-CoA Dehydrogenase Metachromatic Leukodystrophy Methylmalonic Acidemia: MMAA Related Methylmalonic Acidemia: MMAB Related Methylmalonic Acidemia: MUT Related Methylmalonic Aciduria and Homocystinuria: Type cblc MTHFR : Severe Mucolipidosis: Type II/III Mucolipidosis: Type IV [ACMG]* Multiple Pterygium Syndrome Multiple Sulfatase Muscle-Eye-Brain Disease Myotubular Myopathy: X-Linked Navajo Neurohepatopathy Nemaline Myopathy: NEB Related Nephrotic Syndrome: Type 1 Nephrotic Syndrome: Type 2 CLN3 Related CLN5 Related CLN6 Related CLN8 Related MFSD8 Related PPT1 Related TPP1 Related Niemann-Pick Disease: Type A [ACMG]* Niemann-Pick Disease: Type B Niemann-Pick Disease: Type C1 Niemann-Pick Disease: Type C2 Nijmegen Breakage Syndrome Nonsyndromic Hearing Loss and Deafness: DFNB3 Related Nonsyndromic Hearing Loss and Deafness: GJB2 Related Oculocutaneous Albinism: Type 1 Oculocutaneous Albinism: Type 4 Omenn Syndrome Ornithine Transcarbamylase Ornithine Translocase Pendred Syndrome Persistent Mullerian Duct Syndrome: Type I Persistent Mullerian Duct Syndrome: Type II Phenylalanine Hydroxylase POLG Related Disorders: Autosomal Recessive Polyglandular Autoimmune Syndrome: Type 1 Primary Carnitine Primary Hyperoxaluria: Type 1 Primary Hyperoxaluria: Type 2 Primary Hyperoxaluria: Type 3 Progressive Familial Intrahepatic Cholestasis: Type 2 Propionic Acidemia: PCCA Related Propionic Acidemia: PCCB Related Pseudocholinesterase Pycnodysostosis Pyruvate Dehydrogenase : Autosomal Recessive Pyruvate Dehydrogenase : X-Linked Retinal Dystrophies: RLBP1 Related Retinitis Pigmentosa: Autosomal Recessive: DHDDS Related Rhizomelic Chondrodysplasia Punctata: Type 1 Salla Disease Sanfilippo Syndrome: Type A Sanfilippo Syndrome: Type B Sanfilippo Syndrome: Type C Sanfilippo Syndrome: Type D SCID: X-Linked Short-Chain Acyl-CoA Dehydrogenase Sickle-Cell Anemia [ACOG]* Sjogren-Larsson Syndrome Smith-Lemli-Opitz Syndrome Spinal Muscular Atrophy: SMN1 Related [ACMG]* Stargardt Disease Stuve-Wiedemann Syndrome Sulfate Transporter-Related Osteochondrodysplasia Tay-Sachs Disease [ACOG/ACMG]* Tyrosine Hydroxylase Tyrosinemia: Type I Usher Syndrome: Type 1B Usher Syndrome: Type 1C Usher Syndrome: Type 1D Usher Syndrome: Type 1F Usher Syndrome: Type 2A Usher Syndrome: Type 3 Very Long-Chain Acyl-CoA Dehydrogenase Walker-Warburg Syndrome Werner Syndrome Wilson Disease Wolcott-Rallison Syndrome PEX1 Related PEX2 Related PEX6 Related PEX10 Related
6 Chile Río refugio 9641 Pudahuel, Santiago info@tag-genetics.com China 102#, 1009 Yishan Road Xuhui Districtl, Shangai info@tag-genetics.cn México Av. Coyoacán #1622 Local 207, Colonia del Valle Delegación Benito Juarez D.F info@tag-genetics.com.mx
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationAll diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationCarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List
Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More information23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function
1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:
More informationPATIENT EDUCATION. carrier screening INFORMATION
PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationHigh Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
More informationCARRIER SCREEN - LIST OF DISORDERS
1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase
More informationA Lawyer s Perspective on Genetic Screening Performed by Cryobanks
A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child
More informationForesight Carrier Screen
Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:
More informationFamily Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis
123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationShould Universal Carrier Screening be Universal?
Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden
More informationJOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary
Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:
More informationResidual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
More informationThe Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem
The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non
More informationThe Counsyl Foresight Carrier Screen
The Counsyl Foresight Carrier Screen 180 Kimball Way South San Francisco, CA 94080 www.counsyl.com contact@counsyl.com (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient
More informationHERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
More informationNewborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
More informationSummary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia
Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. SAPLE REPORT CARRIER STATUS DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Asian ORDERING HEALTHCARE PROFESSIONAL
More informationExpanded Carrier Screening: What s Best?
Expanded Carrier Screening: What s Best? James D Goldberg, MD September 17, 2017 Disclosures James D. Goldberg, M.D. Chief Medical Officer, Counsyl 3 Learning Objectives Guidelines Data Design Practice
More informationEvolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
More informationEVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.
EVOLVE CARRIER GENETIC SCREENS Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. PROTECT THE HEALTH OF YOUR FUTURE CHILDREN BY KNOWING YOUR GENETIC RISKS, TODAY! Carrier
More informationORIGINAL RESEARCH ARTICLE
American College of Medical Genetics and Genomics Open An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals
More informationOverview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy
Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More informationFor Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More informationA. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia
OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR
More information[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
More informationPREDICAGEN LLC REPORT
The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because
More information23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert
Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro
More informationWhen users open the application interface, the starting page presents a disclaimer. Upon agreeing to the
Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search
More informationRelated Policies None
Medical Policy MP 2.04.107 BCBSA Ref. Policy: 2.04.107 Last Review: 04/30/2018 Effective Date: 04/30/0218 Section: Medicine Related Policies None DISCLAIMER Our medical policies are designed for informational
More informationDiagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
More informationCOMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS
COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /
More informationResults Recipient Ordering Healthcare Professional Male Details Female Details
Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL
More informationPositive Newborn Screens: What do you do next?
Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric
More informationGenetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION
Carrier Screening and Diagnostic Testing for the Ashkenazi Jewish Population Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Our Science. Your Care. An extensive
More informationSperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic
Sperm Donor Profile This packet is for informational purposes. All the questions have been answered by the donor and are unaltered with exception to the staff impressions, genetic screening results, and
More information(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;
Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits
More informationQUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.
Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:
More information23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert
Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationCarrier Screening for Genetic Diseases
Medical Policy Manual Genetic Testing, Policy No. 81 Carrier Screening for Genetic Diseases Next Review: September 2018 Last Review: December 2017 Effective: January 1, 2018 IMPORTANT REMINDER Medical
More informationHA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up
HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors
More informationTable S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database
Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)
More informationExpanded carrier screening for monogenic disorders: where are we now?
DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and
More informationA Guide for Prenatal Educators
A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of
More informationPreconceptional Test For Monogenic Diseases
Preconceptional Test For Monogenic Diseases Dr. José A. Horcajadas Associate Professor, U. Pablo de Olavide, Seville, Spain Research Associate Professor, EVMS, Norfolk, Virginia, US CSO, Recombine Europe,
More informationMost common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationGENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS
Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members
More informationGeneral Approach to Genetic Testing
Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,
More informationBeyond the case for NBS in South Africa. Chris Vorster 28/05/2016
Beyond the case for NBS in South Africa Chris Vorster 28/05/2016 The case for NBS in SA Economic justification Cost Utility analysis = Cost/QALY GDP/Capita Immediate implementation (WHO) Political justification
More informationCorporate Medical Policy
Corporate Medical Policy Carrier Screening for Genetic Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carrier_screening_for_genetic_disease 12/2013 7/2017 7/2018 7/2017
More informationMedical Policy Preimplantation Genetic Testing
Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial
More informationMISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]
More informationNEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationStandard Therapies - Cord Blood
A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical
More informationTitle: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
More informationdisease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE
123 Main Street City, CA 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: EDTA Blood Date of Collection: 02/06/2014 Date Received: 02/16/2014 Date Tested: 02/16/2014 Indication: Screening
More informationPGD: A Celebration of 20 years:
PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,
More informationNewborn Screening: Blood Spot Disorders
Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical
More informationNEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4
More informationרשימת המחלות הנסקרות בבדיקה
רשימת המחלות הנסקרות בבדיקה By סקר גנטי טרום הריון - FamilyFirst בדיקת סקר גנטי טרום הריוני מורחב, הסוקרת כ- 850 מוטציות העלולות לחולל 255 מחלות תורשתיות. הבדיקה כוללת את כל המחלות המומלצות ע"י משרד הבריאות
More informationBULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)
BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National
More informationArchived Reports Summary
Archived Reports Summary 1 Archived Reports Summary This summary provides information that may be helpful when viewing your archived reports. The information in this document and in your reports is intended
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationThe Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot
The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State Caroline T. Nucup-Villaruz, MD Primary Author NBS Consultant - Disorder FU Santosh Shaunak Co-Author & Presenter Laboratory
More informationBE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.
BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. THE LEADER IN FERTILITY & REPRODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in preventive and personalized healthcare, with over 25 years
More informationSurvey of prenatal testing for genetic disorders in Japan: Recent report
doi:10.1111/jog.12948 J. Obstet. Gynaecol. Res. Vol. 42, No. 4: 375 379, April 2016 Survey of prenatal testing for genetic disorders in Japan: Recent report Takahiro Nobuzane 1, Takahiro Yamada 2,KiyonoriMiura
More informationNewborn Screening in Manitoba. Information for Health Care Providers
Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria
More informationConsiderations in Choosing Screening Conditions: One (US) Approach
22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States
More informationCARRIER SCREENING PANEL
1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance
More informationApproach to diagnosis of metabolic diseases
Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationBeyond Mendel s Laws of Inheritance
Beyond Mendel s Laws of Inheritance 2006-2007 Extending Mendelian genetics Mendel worked with a simple system peas are genetically simple most traits are controlled by a single gene each gene has only
More informationOur partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.
CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to
More informationOriginal Policy Date
MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer
More informationTEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647
Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European
More informationKnowledge is power. Plan ahead with GeneAware.
MATERNAL FETAL Many patients may have questions regarding specific genetic disorders that may arise when planning or expecting a baby. That s why Baylor Genetics developed GeneAware, a reproductive carrier
More informationgenetic carrier screening for cystic fibrosis results you Can trust
genetic carrier screening for cystic fibrosis results you Can trust Cystic Fibrosis Carrier Screening Why Carrier Screening for Cystic Fibrosis Is Important? Carrier screening tests help identify individuals
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationNEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationNEWBORN METABOLIC SCREEN, MINNESOTA
Lab Dept: Test Name: Chemistry NEWBORN METABOLIC SCREEN, MINNESOTA General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: PKUN Newborn Screen for Hyopothyroidism, Phenylketonuria (PKU),
More informationExpanded carrier screening in an infertile population: how often is clinical decision making affected?
American College of Medical Genetics and Genomics Original Research Article Expanded carrier screening in an infertile population: how often is clinical decision making affected? Jason M. Franasiak, MD
More informationNewborn Screening in Washington State Saving lives with a simple blood spot
Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video
More informationSema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations
Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered
More informationFamily Medical History Questionnaire (FMHQ)
First, Last Name DOB: Cord Blood Bank Use Only: Family Medical History Questionnaire (FMHQ) NMDP CBU ID: Local CBU ID: NMDP Maternal ID: Today's Date: Local Maternal ID: Baby's Mother's Initials: Please
More informationFAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM
THE ESSENTIAL PANEL There are many unknowns in life. FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM PLANNING FOR A FAMILY IS A BIG DECISION TAKE STEPS TOWARD A HEALTHY FUTURE WITH NXGEN GENETIC CARRIER
More informationTIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN
TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively
More informationWhat s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of
More information